CRP and Crohn disease: lnc-ITSN1-2 expression also correlates with disease risk and active disease status of IBD, and it positively correlates with CRP, ESR, and Crohn’s disease activity index in patients with active Crohn’s disease (CD) (Nie and Zhao 2020).